Reichardt, Holger, Prof. Dr.

Professor of Experimental Immunology

• 1989-1994: Studies in Biochemistry at the Universities of Tübingen, Munich and Fribourg/Switzerland
• 1994-1997: PhD thesis at the German Cancer Research Center and the University of Heidelberg
• 1997-2001: Junior group leader with Günther Schütz, German Cancer Research Center Heidelberg
• 2001-2002: Independent group leader, Institute for Virology and Immunobiology, University of Würzburg
• 2002-2006: Professor of Molecular Immunology, University of Würzburg
• since 2007: Professor of Experimental Immunology, University of Göttingen

Major Research Interests
Inflammatory diseases such as Multiple Sclerosis, Type I Diabetes mellitus, Asthma and Graft-versus-Host-Disease are major health problems in the western world, often require lifetime medical treatment and may result in permanent disability and early death. Generally, therapy is often unsatisfactory and accompanied by side effects. Therefore our work aims at better understanding the mechanisms underlying traditional and new treatment regimens for chronic inflammatory diseases. First and foremost our approaches concern the mode of action of glucocorticoids, which are still the mainstay of many therapies employed in the clinic. To accomplish our goal, we primarily focus on T lymphocytes and myeloid cells and use a plethora of molecular and immunological techniques, different cell culture systems and a variety of animal models. Since glucocorticoid therapy is accompanied by metabolic side effects, some approaches in the lab also deal with the impact of anti-inflammatory therapies on muscle, liver, bone and the gastrointestinal tract. All our projects are integrated in a dense network of cooperation involving colleagues from allover the world.

Homepage Department/Research Group
http://www.immunologie.uni-goettingen.de

ORCID: 0000-0003-4647-057X